APPLICATION OF CD45 AS BIOMARKER IN SCREENING EFFECTIVENESS AND PRECISION OF CD26 ANTIBODY OR DERIVATIVE THEREOF IN TREATING TUMORS

APPLICATION OF CD45 AS BIOMARKER IN SCREENING EFFECTIVENESS AND PRECISION OF CD26 ANTIBODY OR DERIVATIVE THEREOF IN TREATING TUMORS

Provided is an application of CD45 as a biomarker in screening the effectiveness of a CD26 antibody or a derivative thereof in treating tumors in a test subject. Specifically, when CD45 is not expressed or has low expression, determining that the treatment of the test subject who has received a CD26...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HANG, Jianhua, CAO, Peipei, GE, Chennan, MA, Bruce Yong
Format: Patent
Sprache:chi ; eng ; fre
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator HANG, Jianhua
CAO, Peipei
GE, Chennan
MA, Bruce Yong
description Provided is an application of CD45 as a biomarker in screening the effectiveness of a CD26 antibody or a derivative thereof in treating tumors in a test subject. Specifically, when CD45 is not expressed or has low expression, determining that the treatment of the test subject who has received a CD26 antibody or a derivative thereof is effective or has a high probability of being effective; and when CD45 expression is high or relatively high, determining that the treatment of the test subject who has received a CD26 antibody or a derivative thereof is ineffective or has a high probability of being ineffective. By filtering-out a biomarker capable of effectively screening the tumor treatment effectiveness of a CD26 antibody or derivative thereof, it is possible to greatly improve the precision and effectiveness of tumor treatment by the CD26 antibody or derivative thereof, thus improving the clinical benefit to the patient; it has been found that CD26 acts as a new mechanism for treatment effectiveness and prec
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2023143245A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2023143245A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2023143245A13</originalsourceid><addsrcrecordid>eNqNjLEKwjAURbs4iPoPD5wFm1b3NH2xD21SXmLFqRSJk2ih_oE_bgRxdrpwOOdOk5dsmgMp6ckasBpUmW9AOijI1pL3yEAGnGJEQ2YHqDUqTy0adA6kKaFhVOR-tdhG6qmw5RksQ4lMrfwE4CtkjE7884yRxTt_rC27eTK59rcxLL47S5YavapWYXh0YRz6S7iHZ3eyYi2yNM9EvpFp9p_1BqW9PVM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>APPLICATION OF CD45 AS BIOMARKER IN SCREENING EFFECTIVENESS AND PRECISION OF CD26 ANTIBODY OR DERIVATIVE THEREOF IN TREATING TUMORS</title><source>esp@cenet</source><creator>HANG, Jianhua ; CAO, Peipei ; GE, Chennan ; MA, Bruce Yong</creator><creatorcontrib>HANG, Jianhua ; CAO, Peipei ; GE, Chennan ; MA, Bruce Yong</creatorcontrib><description>Provided is an application of CD45 as a biomarker in screening the effectiveness of a CD26 antibody or a derivative thereof in treating tumors in a test subject. Specifically, when CD45 is not expressed or has low expression, determining that the treatment of the test subject who has received a CD26 antibody or a derivative thereof is effective or has a high probability of being effective; and when CD45 expression is high or relatively high, determining that the treatment of the test subject who has received a CD26 antibody or a derivative thereof is ineffective or has a high probability of being ineffective. By filtering-out a biomarker capable of effectively screening the tumor treatment effectiveness of a CD26 antibody or derivative thereof, it is possible to greatly improve the precision and effectiveness of tumor treatment by the CD26 antibody or derivative thereof, thus improving the clinical benefit to the patient; it has been found that CD26 acts as a new mechanism for treatment effectiveness and prec</description><language>chi ; eng ; fre</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230803&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023143245A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,781,886,25569,76552</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230803&amp;DB=EPODOC&amp;CC=WO&amp;NR=2023143245A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HANG, Jianhua</creatorcontrib><creatorcontrib>CAO, Peipei</creatorcontrib><creatorcontrib>GE, Chennan</creatorcontrib><creatorcontrib>MA, Bruce Yong</creatorcontrib><title>APPLICATION OF CD45 AS BIOMARKER IN SCREENING EFFECTIVENESS AND PRECISION OF CD26 ANTIBODY OR DERIVATIVE THEREOF IN TREATING TUMORS</title><description>Provided is an application of CD45 as a biomarker in screening the effectiveness of a CD26 antibody or a derivative thereof in treating tumors in a test subject. Specifically, when CD45 is not expressed or has low expression, determining that the treatment of the test subject who has received a CD26 antibody or a derivative thereof is effective or has a high probability of being effective; and when CD45 expression is high or relatively high, determining that the treatment of the test subject who has received a CD26 antibody or a derivative thereof is ineffective or has a high probability of being ineffective. By filtering-out a biomarker capable of effectively screening the tumor treatment effectiveness of a CD26 antibody or derivative thereof, it is possible to greatly improve the precision and effectiveness of tumor treatment by the CD26 antibody or derivative thereof, thus improving the clinical benefit to the patient; it has been found that CD26 acts as a new mechanism for treatment effectiveness and prec</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjLEKwjAURbs4iPoPD5wFm1b3NH2xD21SXmLFqRSJk2ih_oE_bgRxdrpwOOdOk5dsmgMp6ckasBpUmW9AOijI1pL3yEAGnGJEQ2YHqDUqTy0adA6kKaFhVOR-tdhG6qmw5RksQ4lMrfwE4CtkjE7884yRxTt_rC27eTK59rcxLL47S5YavapWYXh0YRz6S7iHZ3eyYi2yNM9EvpFp9p_1BqW9PVM</recordid><startdate>20230803</startdate><enddate>20230803</enddate><creator>HANG, Jianhua</creator><creator>CAO, Peipei</creator><creator>GE, Chennan</creator><creator>MA, Bruce Yong</creator><scope>EVB</scope></search><sort><creationdate>20230803</creationdate><title>APPLICATION OF CD45 AS BIOMARKER IN SCREENING EFFECTIVENESS AND PRECISION OF CD26 ANTIBODY OR DERIVATIVE THEREOF IN TREATING TUMORS</title><author>HANG, Jianhua ; CAO, Peipei ; GE, Chennan ; MA, Bruce Yong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2023143245A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng ; fre</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HANG, Jianhua</creatorcontrib><creatorcontrib>CAO, Peipei</creatorcontrib><creatorcontrib>GE, Chennan</creatorcontrib><creatorcontrib>MA, Bruce Yong</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HANG, Jianhua</au><au>CAO, Peipei</au><au>GE, Chennan</au><au>MA, Bruce Yong</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>APPLICATION OF CD45 AS BIOMARKER IN SCREENING EFFECTIVENESS AND PRECISION OF CD26 ANTIBODY OR DERIVATIVE THEREOF IN TREATING TUMORS</title><date>2023-08-03</date><risdate>2023</risdate><abstract>Provided is an application of CD45 as a biomarker in screening the effectiveness of a CD26 antibody or a derivative thereof in treating tumors in a test subject. Specifically, when CD45 is not expressed or has low expression, determining that the treatment of the test subject who has received a CD26 antibody or a derivative thereof is effective or has a high probability of being effective; and when CD45 expression is high or relatively high, determining that the treatment of the test subject who has received a CD26 antibody or a derivative thereof is ineffective or has a high probability of being ineffective. By filtering-out a biomarker capable of effectively screening the tumor treatment effectiveness of a CD26 antibody or derivative thereof, it is possible to greatly improve the precision and effectiveness of tumor treatment by the CD26 antibody or derivative thereof, thus improving the clinical benefit to the patient; it has been found that CD26 acts as a new mechanism for treatment effectiveness and prec</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng ; fre
recordid cdi_epo_espacenet_WO2023143245A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title APPLICATION OF CD45 AS BIOMARKER IN SCREENING EFFECTIVENESS AND PRECISION OF CD26 ANTIBODY OR DERIVATIVE THEREOF IN TREATING TUMORS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T14%3A56%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HANG,%20Jianhua&rft.date=2023-08-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2023143245A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true